Skip to main content
Log in

Susceptibility ofMycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The susceptibility ofMycobacterium kansasii to antibacterial agents alone and in combination was studied. Widespread resistance to ethambutol, ciprofloxacin and isoniazid was found when these drugs were tested separately. However, pronounced antibacterial effects were seen when ethambutol was tested in combination with ciprofloxacin, rifampicin or rifabutin, which corresponded to significantly decreased resistance to these drugs in combination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hoffner SE, Svenson SB, Källenius G Synergistic effects of antimycobacterial drugs onMycobacterium avium complex determined radiometrically in liquid medium. European Journal of Clinical Microbiology 1987, 6: 530–535.

    PubMed  Google Scholar 

  2. Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Källenius G In vitro synergistic activity between ethambutol and flourinated quinolones againstMycobacterium avium complex. Journal of Antimicrobial Chemotherapy 1989, 24: 317–324.

    PubMed  Google Scholar 

  3. Kubín M, Svandová E, Medek B, Chobot S, Olsovsky Z Mycobacterium kansasii infections in an endemic area of Czechoslovakia. Tubercle 1980, 61: 107–112.

    Google Scholar 

  4. Middlebrook G, Reggiardo Z, Tigertt WD Automatable radiometric detection of growth ofMycobacterium tuberculosis in selective media. American Reviews of Respiratory Diseases 1977, 115: 1066–1069.

    Google Scholar 

  5. Heifets LB, Iseman MD Determination of in vitro susceptibility of mycobacteria to ansamycin. American Reviews of Respiratory Diseases 1985, 132: 710–711.

    Google Scholar 

  6. Good RC, Silcox VA, Kilburn JO, Plikaytis BD Identification and drug susceptibility test results forMycobacterium spp. Clinical Microbiology Newsletter 1985, 7: 133–136.

    Google Scholar 

  7. Heifets LB, Iseman MD, Lindholm-Levy PJ, Kanes W Determinations of ansamycin MICs forMycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrobial Agents and Chemotherapy 1985, 28: 565–578.

    PubMed  Google Scholar 

  8. David HL Basis for lack of drug susceptibility of atypical mycobacteria. Reviews of Infectious Diseases 1981, 3: 878–884.

    PubMed  Google Scholar 

  9. Rastogi N, Frehel C, Ryter A, Ohayon H, Lesourd M, David HL Multiple drug resistance inMycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? Antimicrobial Agents and Chemotherapy 1981, 20: 666–677.

    PubMed  Google Scholar 

  10. Hoffner SE, Källenius G, Beezer AE, Svenson SB Studies on the mechanisms of the synergistic effects of ethambutol and other antibacterial drugs onMycobacterium avium complex. Acta Leprologica 1989, 7, Supplement 1: 195–199.

    PubMed  Google Scholar 

  11. Källenius G, Svenson SB, Hoffner SE Ethambutol: a key forMycobacterium avium complex chemotherapy? American Reviews of Respiratory Diseases 1989, 140: 264.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hjelm, U., Kaustová, J., Kubín, M. et al. Susceptibility ofMycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. Eur. J. Clin. Microbiol. Infect. Dis. 11, 51–54 (1992). https://doi.org/10.1007/BF01971272

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01971272

Keywords

Navigation